Friedemann Paul Selected Research

Antibodies

1/2023	Immunoglobulin A Antibodies Against Myelin Oligodendrocyte Glycoprotein in a Subgroup of Patients With Central Nervous System Demyelination.
1/2023	Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria.
4/2022	CSF GFAP levels in double seronegative neuromyelitis optica spectrum disorder: no evidence of astrocyte damage.
1/2022	SARS-CoV-2 mRNA vaccinations fail to elicit humoral and cellular immune responses in patients with multiple sclerosis receiving fingolimod.
10/2021	Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination.
8/2021	Asian and African/Caribbean AQP4-NMOSD patient outcomes according to self-identified race and place of residence.
1/2021	Myelin-oligodendrocyte glycoprotein antibody-associated disease.
11/2020	Anti-MOG antibody-associated disorders: differences in clinical profiles and prognosis in Japan and Germany.
1/2020	Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis.
1/2020	New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Friedemann Paul Research Topics

Disease

132	Multiple Sclerosis 02/2024 - 07/2007
92	Neuromyelitis Optica (Devic's Disease) 06/2024 - 04/2007
46	Optic Neuritis (Retrobulbar Neuritis) 12/2023 - 04/2008
34	Ganglion Cysts (Ganglion) 01/2023 - 08/2015
25	Relapsing-Remitting Multiple Sclerosis 01/2023 - 07/2007
20	Inflammation (Inflammations) 03/2024 - 09/2013
17	Neuroinflammatory Diseases 01/2024 - 05/2013
15	Encephalitis (Encephalitis, Rasmussen) 10/2023 - 01/2013
14	Demyelinating Diseases (Demyelinating Disease) 12/2023 - 09/2013
13	Atrophy 10/2023 - 10/2010
12	Autoimmune Diseases (Autoimmune Disease) 09/2023 - 04/2007
12	Myelitis 01/2023 - 01/2016
10	COVID-19 06/2024 - 01/2021
9	Infections 09/2023 - 01/2012
8	Disease Progression 03/2024 - 10/2014
8	Central Nervous System Diseases (CNS Diseases) 01/2023 - 01/2016
8	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 10/2022 - 09/2013
7	Encephalomyelitis (Myeloencephalitis) 07/2023 - 12/2009
7	Nervous System Diseases (Neurological Disorders) 09/2021 - 11/2010
7	Susac Syndrome 01/2019 - 01/2012
6	Cognitive Dysfunction 02/2024 - 08/2014
6	Fatigue 09/2023 - 01/2014
6	Autoimmune Diseases of the Nervous System 06/2023 - 08/2013
6	Transverse Myelitis (Necrotizing Myelitis) 01/2023 - 04/2007
6	Parkinson Disease (Parkinson's Disease) 05/2022 - 08/2014
5	Pain (Aches) 01/2022 - 12/2016
5	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 07/2013
5	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 04/2021 - 01/2011
4	Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) 09/2023 - 01/2022
4	Neoplasms (Cancer) 06/2023 - 01/2011
4	Ataxia (Dyssynergia) 01/2021 - 08/2014
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 02/2013
3	Obesity 11/2023 - 12/2022
3	Seizures (Absence Seizure) 06/2023 - 09/2007
3	Headache (Headaches) 01/2023 - 10/2015
3	Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis) 01/2023 - 09/2020
3	Epstein-Barr Virus Infections 01/2023 - 08/2015
3	Dementia (Dementias) 05/2022 - 07/2013
3	Multiple System Atrophy 06/2021 - 04/2016
3	Rubella (German Measles) 09/2020 - 08/2015
3	Vision Disorders (Hemeralopia) 01/2017 - 11/2013
3	Leukocytosis (Pleocytosis) 11/2016 - 01/2012
3	Retinal Artery Occlusion 02/2016 - 06/2013
2	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 10/2023 - 04/2016
2	Cerebellar Ataxia (Dysmetria) 09/2023 - 01/2019
2	Dyskinesias (Dyskinesia) 06/2023 - 10/2016
2	Hypoxia (Hypoxemia) 01/2023 - 01/2018
2	Chronic Progressive Multiple Sclerosis 01/2023 - 01/2012
2	Meningococcal Infections 01/2023 - 01/2018

Drug/Important Bio-Agent (IBA)

76	Retinaldehyde (Retinal)IBA 10/2023 - 12/2009
50	Immunoglobulin G (IgG)IBA 06/2024 - 05/2007
45	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2013
42	Myelin-Oligodendrocyte GlycoproteinIBA 01/2024 - 01/2016
37	AntibodiesIBA 01/2023 - 04/2007
23	AutoantibodiesIBA 11/2023 - 09/2011
14	Proteins (Proteins, Gene)FDA Link 02/2024 - 11/2014
9	inebilizumabIBA 06/2024 - 10/2019
9	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 10/2023 - 08/2013
9	Oligoclonal BandsIBA 01/2023 - 01/2012
7	Aquaporin 4IBA 10/2023 - 04/2007
7	Aquaporins (Water Channels)IBA 12/2022 - 02/2012
7	Fingolimod Hydrochloride (FTY720)FDA Link 03/2022 - 11/2013
7	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2021 - 01/2015
6	Complement System Proteins (Complement)IBA 01/2024 - 11/2014
6	Vitamin D FDA LinkGeneric 01/2023 - 02/2012
6	anti-aquaporin 4 autoantibodyIBA 01/2018 - 09/2010
5	CytokinesIBA 01/2024 - 01/2017
5	GadoliniumIBA 10/2022 - 07/2017
5	Natalizumab (Tysabri)FDA Link 01/2020 - 02/2012
4	Immunoglobulins (Immunoglobulin)IBA 01/2023 - 08/2015
4	Immunoglobulin A (IgA)IBA 01/2023 - 10/2014
4	Peptides (Polypeptides)IBA 10/2021 - 01/2016
4	protein kinase C gamma (PRKCG)IBA 04/2021 - 08/2015
4	Glatiramer Acetate (Copaxone)FDA Link 01/2021 - 07/2007
4	Immunoglobulin M (IgM)IBA 09/2020 - 10/2014
4	SteroidsIBA 01/2018 - 06/2016
3	InterferonsIBA 03/2024 - 01/2013
3	Indicators and Reagents (Reagents)IBA 03/2024 - 01/2013
3	AntigensIBA 01/2024 - 06/2013
3	Sphingosine-1-Phosphate ReceptorsIBA 01/2023 - 12/2018
3	Glial Fibrillary Acidic ProteinIBA 01/2023 - 11/2022
3	Methylprednisolone FDA LinkGeneric 01/2023 - 12/2009
3	eculizumab FDA Link 12/2022 - 06/2013
3	EnzymesIBA 01/2022 - 12/2015
3	teriflunomideIBA 01/2022 - 01/2021
3	Dihydroorotate DehydrogenaseIBA 01/2022 - 01/2020
3	VaccinesIBA 01/2022 - 01/2011
3	Polysaccharides (Glycans)IBA 01/2021 - 01/2020
3	Therapeutic UsesIBA 01/2020 - 02/2012
3	EpitopesIBA 10/2016 - 07/2014
2	AcidsIBA 03/2024 - 10/2016
2	Interleukin-17 (Interleukin 17)IBA 01/2024 - 01/2023
2	Hormones (Hormone)IBA 11/2023 - 01/2022
2	Synapsins (Synapsin I)IBA 11/2023 - 11/2017
2	Monoclonal AntibodiesIBA 10/2023 - 01/2021
2	FluorineIBA 01/2023 - 01/2021
2	Oxygen (Dioxygen)IBA 01/2023 - 10/2015
2	gadobutrolIBA 10/2022 - 06/2017

Therapy/Procedure

34	Therapeutics 06/2024 - 10/2010
10	Immunotherapy 09/2023 - 11/2013